of peptides and, thus, their mode of biological action,
incorporation of sterically defined R,â-dialkyl-substituted
R-amino acids into peptides would provide a powerful tool
for exploration of peptide-mediated biological information
transfer.3,4
Asymmetric synthesis of the target amino acids is virtually
undeveloped, however.2 To the best of our knowledge only
a recent report by the Davis group offers a relatively
generalized approach to R,â-dialkyl-substituted R-amino
acids via stepwise introduction of the required functional-
ities.5 A more methodologically concise approach to the
target amino acids would be by direct alkylation of chiral
derivatives of alanine with racemic sec-alkyl halides.6 In this
Letter, we report the reactions between a chiral Ni(II)-
complex of alanine (S)(S,R)-17 (Scheme 1) with a series of
alanine6 or glycine9 utilized reactions conducted at low
temperatures (-78 °C). Therefore, we were most interested
in developing a process which could be conducted at
synthetically more convenient, higher temperatures, ulti-
mately, room-temperature reactions.
The alkylations of the alanine complex (S)(S,R)-110 with
rac-2a-c (ratio 1/2.5, respectively) were conducted under
our standard conditions: in DMF solutions using powdered
NaOH as a base. The temperature of the reactions was varied
to study its influence on the stereochemical outcome. The
results obtained are given in Table 1. First of all, we were
Table 1. Reactions of (S)(S,R)-1 with 2a-ca
entry
2a -c
T, °C
time, min
yield,b %
ratioc 3/4
1
2
3
4
5
6
7
8
a
a
a
b
b
c
c
c
25
0
-10
25
-10
25
60
90
140
40
140
240
360
480
92
94
94
90
97
90
93
90
5.7/1d
6.2/1
19.0/1
14.9/1
17.0/1
3.0/1
Scheme 1
0
-10
6.0/1
12.0/1
a All reactions were run under an oxygen-free nitrogen atmosphere. Ratio
(S)(S,R)-1/2a-c was 1/2.5. b Combined yield of all diastereomeric products.
c Ratio of diastereomeric products (S)(2S,3R)-3/(S)(2S,3S)-4 was determined
on the crude reaction mixtures by 1H NMR (500 MHz). In particular,
characteristic and well-separated signals of aromatic protons in the region
8.00-8.25 ppm were used for the determination. d Some amounts (<5%)
of (2R)-configured product also were detected in the reaction mixture.
pleased to find that even at room temperature (25 °C) the
alkylation of the alanine complex (S)(S,R)-1 with racemic
R-methylbenzyl bromide (2a) occurred with substantial
stereoselectivity, giving rise to a mixture of diastereomeric
products (S)(2S,3S)-3a and (S)(2S,3R)-4a in a ratio of 5.7 to
1 (entry 1). Lowering the reaction temperature expectedly
decreased the rate of the alkylation (entries 2 and 3 vs 1)
but noticeably increased the enantiomer stereodifferentiation
process allowing preparation of (S)(2S,3S)-3a with syntheti-
cally meaningful diastereoselectivity (90% de) (entry 3). The
major product (S)(2S,3S)-3a was isolated in diastereomeri-
cally pure form simply by washing the reaction mixture with
diethyl ether and was decomposed to give the target (2S,3S)-
R,â-dimethylphenylalanine (5a) in 70% overall yield, along
with the recovered chiral ligand (S)-611 (96%) (Scheme 1).
Alkylation of alanine complex (S)(S,R)-1 at room temperature
with the more sterically demanding R-ethylbenzyl bromide
(2b) gave more impressive results, affording the major
product (S)(2S,3S)-3 with 93.7% diastereoselectivity (entry
4 vs 1). As observed in the reaction between (S)(S,R)-1 with
2a (entries 1-3), lowering the temperature (-10 °C)
increased the selectivity of the enantiomer differentiation
process in the alkylation of (S)(S,R)-1 with 2b (entry 5).
However, the observed diastereoselectivity was lower than
that obtained in the reaction between (S)(S,R)-1 and 2a (entry
5 vs 3). Unexpectedly, a further increase in the steric bulk
of the alkylating agent resulted in decreased diastereoselec-
tivity. Thus, alkylation of (S)(S,R)-1 with R-isobutylbenzyl
racemic 1-bromo-1-phenylalkanes 2a-c,8 which provide a
fast, generalized, and synthetically efficient access to the
target R,â-dialkyl-substituted R-amino acids.
A central issue for the stereochemical outcome of the
reactions between chiral derivatives of alanine with racemic
sec-alkyl halides is the enantiomer-differentiating ability of
the former. A handful of reports describing high enantiomer-
differentiation in the reactions between chiral derivatives of
(5) (a) Davis, F. A.; Liang, C.-H.; Liu, H. J. Org. Chem. 1997, 62, 3796.
(b) Davis, F. A.; Liu, H.; Zhou, P.; Fang, T.; Reddy, G. V.; Zhang, Y. J.
Org. Chem. 1999, 64, 7559.
(6) Kazmierski, W. M.; Urbanczyk-Lipkowska, Z.; Hruby, V. J. J. Org.
Chem. 1994, 59, 1789.
(7) A Ni(II)-complex of the chiral Schiff base of alanine with (S)-o-[N-
(N-benzylprolyl)amino]benzophenone (1) was available from a previous
study: Qiu, W.; Soloshonok, V. A.; Cai, C.; Tang, X.; Hruby, V. J.
Tetrahedron 2000, 56, 2577.
(8) rac-1-Bromo-1-phenylethane (1a) is commercially available; the other
1-bromo-1-phenylalkanes (1b,c) were prepared by dehydroxybromination
of the corresponding benzylic alcohols; see the Supporting Information.
(9) (a) Fitzi, R.; Seebach, D. Tetrahedron 1988, 44, 5277. (b) Seebach,
D.; Hoffmann, M. Eur. J. Org. Chem. 1998, 1337.
(10) Complex 1 prepared from racemic alanine and chiral ligand (S)-6
(see Scheme 1) was obtained and used as a mixture of (S)(R-S) and (S)-
(R-R) diastereomers in a ratio of 9 to 1.
(11) Ligand (S)-6, isolated stereochemically intact, was readily trans-
formed to the starting Ni(II)-complex (S)(S,R)-1.
342
Org. Lett., Vol. 3, No. 3, 2001